APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pruritus Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pruritus Drugs Market Outlook and Growth Opportunities 2026

22 December 2025191 pages

Choose your research edition.

Industry ResearchPruritus Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Pruritus Drugs Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Pruritus Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pruritus Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pruritus Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pruritus Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pruritus Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pruritus Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pruritus Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pruritus Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pruritus Drugs market include Sanofi, Pfizer Inc., GlaxoSmithKline Plc, Astellas Pharma Inc. and Allergan Plc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pruritus Drugs market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pruritus Drugs and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pruritus Drugs revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pruritus Drugs market.

Pruritus Drugs Segment by Company

Sanofi

Pfizer Inc.

GlaxoSmithKline Plc

Astellas Pharma Inc.

Allergan Plc

Pruritus Drugs Segment by Type

Parenteral

Oral

Topical

Pruritus Drugs Segment by Application

Oncological Pruritus

Hematologic Pruritus

Renal Pruritus

Endocrine Pruritus

Cholestatic Pruritus

Pruritus Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pruritus Drugs status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pruritus Drugs key companies, revenue, market share, and recent developments.

3. To split the Pruritus Drugs breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pruritus Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pruritus Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Pruritus Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pruritus Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pruritus Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pruritus Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pruritus Drugs industry.

Chapter 3: Detailed analysis of Pruritus Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pruritus Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pruritus Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pruritus Drugs Industry Trends Table 2. Pruritus Drugs Industry Drivers Table 3. Pruritus Drugs Industry Opportunities and Challenges Table 4. Pruritus Drugs Industry Restraints Table 5. Global Pruritus Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pruritus Drugs Revenue Share by Company (2021-2026) Table 7. Global Pruritus Drugs Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pruritus Drugs Key Company Manufacturing Base & Headquarters Table 9. Global Pruritus Drugs Company, Product Type & Application Table 10. Global Pruritus Drugs Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pruritus Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Parenteral Table 15. Significant Companies of Oral Table 16. Significant Companies of Topical Table 17. Global Pruritus Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Pruritus Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Pruritus Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Pruritus Drugs Sales Value Share by Type (2021-2026) Table 21. Global Pruritus Drugs Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Oncological Pruritus Table 23. Significant Companies of Hematologic Pruritus Table 24. Significant Companies of Renal Pruritus Table 25. Significant Companies of Endocrine Pruritus Table 26. Significant Companies of Cholestatic Pruritus Table 27. Global Pruritus Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pruritus Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Pruritus Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Pruritus Drugs Sales Value Share by Application (2021-2026) Table 31. Global Pruritus Drugs Sales Value Share by Application (2027-2032) Table 32. Global Pruritus Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pruritus Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Pruritus Drugs Sales Value Share by Region (2021-2026) Table 35. Global Pruritus Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Pruritus Drugs Sales Value Share by Region (2027-2032) Table 37. Global Pruritus Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pruritus Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Pruritus Drugs Sales Value Market Share by Country (2021-2026) Table 40. Global Pruritus Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Pruritus Drugs Sales Value Market Share by Country (2027-2032) Table 42. Sanofi Company Information Table 43. Sanofi Business Overview Table 44. Sanofi Pruritus Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Sanofi Pruritus Drugs Product Portfolio Table 46. Sanofi Recent Development Table 47. Pfizer Inc. Company Information Table 48. Pfizer Inc. Business Overview Table 49. Pfizer Inc. Pruritus Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Pfizer Inc. Pruritus Drugs Product Portfolio Table 51. Pfizer Inc. Recent Development Table 52. GlaxoSmithKline Plc Company Information Table 53. GlaxoSmithKline Plc Business Overview Table 54. GlaxoSmithKline Plc Pruritus Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. GlaxoSmithKline Plc Pruritus Drugs Product Portfolio Table 56. GlaxoSmithKline Plc Recent Development Table 57. Astellas Pharma Inc. Company Information Table 58. Astellas Pharma Inc. Business Overview Table 59. Astellas Pharma Inc. Pruritus Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Astellas Pharma Inc. Pruritus Drugs Product Portfolio Table 61. Astellas Pharma Inc. Recent Development Table 62. Allergan Plc Company Information Table 63. Allergan Plc Business Overview Table 64. Allergan Plc Pruritus Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Allergan Plc Pruritus Drugs Product Portfolio Table 66. Allergan Plc Recent Development Table 67. Research Programs/Design for This Report Table 68. Authors List of This Report Table 69. Secondary Sources Table 70. Primary Sources List of Figures Figure 1. Pruritus Drugs Product Image Figure 2. Global Pruritus Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pruritus Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Pruritus Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Parenteral Image Figure 8. Oral Image Figure 9. Topical Image Figure 10. Global Pruritus Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Pruritus Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Pruritus Drugs Sales Value Share by Type (2021-2032) Figure 13. Oncological Pruritus Image Figure 14. Hematologic Pruritus Image Figure 15. Renal Pruritus Image Figure 16. Endocrine Pruritus Image Figure 17. Cholestatic Pruritus Image Figure 18. Global Pruritus Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pruritus Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Pruritus Drugs Sales Value Share by Application (2021-2032) Figure 21. Global Pruritus Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Pruritus Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Pruritus Drugs Sales Value (2021-2032) & (US$ Million) Figure 24. North America Pruritus Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Pruritus Drugs Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Pruritus Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Pruritus Drugs Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Pruritus Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Pruritus Drugs Sales Value (2021-2032) & (US$ Million) Figure 30. South America Pruritus Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Pruritus Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Pruritus Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Pruritus Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Pruritus Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Pruritus Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Parenteral
  • Oral
  • Topical
Applications
  • Oncological Pruritus
  • Hematologic Pruritus
  • Renal Pruritus
  • Endocrine Pruritus
  • Cholestatic Pruritus
Companies covered
  • Sanofi
  • Pfizer Inc.
  • GlaxoSmithKline Plc
  • Astellas Pharma Inc.
  • Allergan Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pruritus Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pruritus Drugs Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pruritus Drugs Market Dynamics
  1. 2.1 Pruritus Drugs Industry Trends
  2. 2.2 Pruritus Drugs Industry Drivers
  3. 2.3 Pruritus Drugs Industry Opportunities and Challenges
  4. 2.4 Pruritus Drugs Industry Restraints
3 Pruritus Drugs Market by Company
  1. 3.1 Global Pruritus Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Pruritus Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Pruritus Drugs Company Ranking (2024-2026)
  4. 3.4 Global Pruritus Drugs Company Manufacturing Base and Headquarters
  5. 3.5 Global Pruritus Drugs Company Product Type and Application
  6. 3.6 Global Pruritus Drugs Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pruritus Drugs Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pruritus Drugs Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pruritus Drugs Market by Type
  1. 4.1 Pruritus Drugs Type Introduction
  2. 4.1.1 Parenteral
  3. 4.1.2 Oral
  4. 4.1.3 Topical
  5. 4.2 Global Pruritus Drugs Sales Value by Type
  6. 4.2.1 Global Pruritus Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pruritus Drugs Sales Value by Type (2021-2032)
  8. 4.2.3 Global Pruritus Drugs Sales Value Share by Type (2021-2032)
5 Pruritus Drugs Market by Application
  1. 5.1 Pruritus Drugs Application Introduction
  2. 5.1.1 Oncological Pruritus
  3. 5.1.2 Hematologic Pruritus
  4. 5.1.3 Renal Pruritus
  5. 5.1.4 Endocrine Pruritus
  6. 5.1.5 Cholestatic Pruritus
  7. 5.2 Global Pruritus Drugs Sales Value by Application
  8. 5.2.1 Global Pruritus Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Pruritus Drugs Sales Value by Application (2021-2032)
  10. 5.2.3 Global Pruritus Drugs Sales Value Share by Application (2021-2032)
6 Pruritus Drugs Regional Value Analysis
  1. 6.1 Global Pruritus Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pruritus Drugs Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pruritus Drugs Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pruritus Drugs Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pruritus Drugs Sales Value (2021-2032)
  7. 6.3.2 North America Pruritus Drugs Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pruritus Drugs Sales Value (2021-2032)
  10. 6.4.2 Europe Pruritus Drugs Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pruritus Drugs Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pruritus Drugs Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pruritus Drugs Sales Value (2021-2032)
  16. 6.6.2 South America Pruritus Drugs Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pruritus Drugs Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pruritus Drugs Sales Value Share by Country, 2025 VS 2032
7 Pruritus Drugs Country-level Value Analysis
  1. 7.1 Global Pruritus Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pruritus Drugs Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pruritus Drugs Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pruritus Drugs Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pruritus Drugs Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pruritus Drugs Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pruritus Drugs Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pruritus Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pruritus Drugs Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pruritus Drugs Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pruritus Drugs Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pruritus Drugs Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pruritus Drugs Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pruritus Drugs Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pruritus Drugs Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pruritus Drugs Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pruritus Drugs Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pruritus Drugs Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pruritus Drugs Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pruritus Drugs Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pruritus Drugs Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pruritus Drugs Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pruritus Drugs Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pruritus Drugs Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pruritus Drugs Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pruritus Drugs Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pruritus Drugs Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pruritus Drugs Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pruritus Drugs Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pruritus Drugs Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pruritus Drugs Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pruritus Drugs Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pruritus Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pruritus Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Pruritus Drugs Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Pruritus Drugs Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Pfizer Inc.
  8. 8.2.1 Pfizer Inc. Company Information
  9. 8.2.2 Pfizer Inc. Business Overview
  10. 8.2.3 Pfizer Inc. Pruritus Drugs Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Inc. Pruritus Drugs Product Portfolio
  12. 8.2.5 Pfizer Inc. Recent Developments
  13. 8.3 GlaxoSmithKline Plc
  14. 8.3.1 GlaxoSmithKline Plc Company Information
  15. 8.3.2 GlaxoSmithKline Plc Business Overview
  16. 8.3.3 GlaxoSmithKline Plc Pruritus Drugs Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Plc Pruritus Drugs Product Portfolio
  18. 8.3.5 GlaxoSmithKline Plc Recent Developments
  19. 8.4 Astellas Pharma Inc.
  20. 8.4.1 Astellas Pharma Inc. Company Information
  21. 8.4.2 Astellas Pharma Inc. Business Overview
  22. 8.4.3 Astellas Pharma Inc. Pruritus Drugs Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Astellas Pharma Inc. Pruritus Drugs Product Portfolio
  24. 8.4.5 Astellas Pharma Inc. Recent Developments
  25. 8.5 Allergan Plc
  26. 8.5.1 Allergan Plc Company Information
  27. 8.5.2 Allergan Plc Business Overview
  28. 8.5.3 Allergan Plc Pruritus Drugs Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Allergan Plc Pruritus Drugs Product Portfolio
  30. 8.5.5 Allergan Plc Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst